20 ACTUAT Zanamivir 5 MG/ACTUAT Dry Powder Inhaler [Relenza]

Known as: Relenza 5 MG/ACTUAT Dry Powder Inhaler, 20 ACTUAT, 20 ACTUAT Relenza 5 MG/ACTUAT Dry Powder Inhaler, RELENZA DISKHALER 5 MG/INHAL Dry Powder Inhaler, 20 Blisters 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The full-resolution next generation impactor (NGI) and three abbreviated impactor systems were used to obtain the apparent… (More)
  • table I
  • table II
  • figure 1
  • table III
  • table IV
Is this relevant?
2016
2016
This work describes a new dry powder for inhalation containing zanamivir, which is less hygroscopic than Relenza®. The powders… (More)
Is this relevant?
Review
2016
Review
2016
BACKGROUND Neuraminidase inhibitors (NIs) are stockpiled and recommended by public health agencies for treating and preventing… (More)
Is this relevant?
2015
2015
BACKGROUND A fatal incident was reported when a mechanical ventilated patient received nebulization of a reconstituted Relenza… (More)
Is this relevant?
2015
2015
The US pharmacopeia (USP) and Alberta throats were recently reported to cause further de-agglomeration of carrier-free powders… (More)
  • table I
  • figure 1
  • table II
  • figure 2
  • figure 3
Is this relevant?
2014
2014
The neuraminidase inhibitors oseltamivir phosphate (Tamiflu®), zanamivir (Relenza®), laninamivir octanoate (Inavir®), and… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2009
Review
2009
In this work, we study the consequences of sequence variations of the "2009 H1N1" (swine or Mexican flu) influenza A virus strain… (More)
  • figure 5
Is this relevant?